Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-31

Clinical Trial Update: Treatment of Facial Flushing With Botulinum Toxin A Injections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Botulinum toxin A injections to treat facial flushing. The study is not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OnabotulinumtoxinA (Botox) (Botulinum toxin type A)

Snippet

Sponsor: Northwestern University | Conditions: Facial Flushing | Phase 4 | Status: ACTIVE_NOT_RECRUITING